Related Experiment Video
Updated: Jan 26, 2026

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
Published on: May 22, 2018
Computational models explain how copper binding to amyloid-β peptide oligomers enhances oxidative pathways
Giovanni La Penna1, Mai Suan Li
1National Research Council of Italy (CNR), Institute for Chemistry of Organometallic Compounds (ICCOM), via Madonna del Piano 10, 50019 Sesto Fiorentino, Firenze, Italy. giovanni.lapenna@cnr.it.
Copper-amyloid-beta interactions catalyze reactive oxygen species, a key factor in Alzheimer's disease (AD). This study reveals structures of copper-amyloid-beta dimers that promote oxidative pathways and Tyr-Tyr crosslink formation, contributing to AD pathogenesis.
Area of Science:
- Biochemistry
- Neuroscience
- Structural Biology
Background:
- Amyloid-beta (Aβ) aggregation is a hallmark of Alzheimer's disease (AD).
- Copper-Aβ interactions generate reactive oxygen species (ROS), linked to AD onset.
- Previous studies confirmed Cu-Aβ catalysis of Tyr-Tyr crosslinks in peptide dimers.
Purpose of the Study:
- Provide a structural basis for observed Cu-Aβ oxidative reactivity.
- Describe Cu-Aβ dimer structures that enhance oxidative pathways.
- Elucidate the role of copper in Aβ crosslinking and aggregation.
Main Methods:
- Structural analysis of copper-amyloid-beta (Cu-Aβ) dimers.
- Investigating the propagation of oxidative pathways around the copper center.
- Correlating structural findings with experimental data on crosslinking and peptide assembly.
Main Results:
- Identified Cu-Aβ dimer structures that propagate oxidative pathways.
- Demonstrated that copper bridging between peptides enhances Tyr-Tyr crosslink formation.
- Observed peptide assembly into dimers and tetramers, consistent with experimental data.
Conclusions:
- Structural insights into Cu-Aβ interactions explain enhanced oxidative reactivity.
- Copper-mediated crosslinking facilitates Aβ peptide assembly into larger oligomers.
- Findings contribute to understanding the molecular mechanisms of Alzheimer's disease.
Related Concept Videos
TGF - β Signaling Pathway
Nitric Oxide Signaling Pathway
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Peptide Bonds
Oxidation Numbers

